Lataa...
A Profiling Platform for the Identification of Selective Metalloprotease Inhibitors
Although proteases represent an estimated 5% to 10% of potential drug targets, inhibitors for metalloproteases (MPs) account for only a small proportion of all approved drugs, failures of which have typically been associated with lack of selectivity. In this study, the authors describe a novel and u...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2365505/ https://ncbi.nlm.nih.gov/pubmed/18349423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1087057108315877 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|